A Synergistic Combination of Niclosamide and Doxorubicin as an Efficacious Therapy for All Clinical Subtypes of Breast Cancer
Drug resistance is one of the major hurdles in the success of cancer chemotherapy. Notably, aberrantly expressed Wnt/β-catenin signaling plays a major role in the initiation and maintenance of oncogenesis along with development of chemoresistance. Therefore, the combinatorial approach of targeting W...
Main Authors: | Garima Lohiya, Dhirendra S. Katti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/13/3299 |
Similar Items
-
Niclosamide from an anthelmintic drug to a promising adjuvant therapy for diabetic kidney disease: randomized clinical trial
by: Basma Mahrous El-fatatry, et al.
Published: (2023-02-01) -
Niclosamide is a potential candidate for the treatment of chemo-resistant osteosarcoma
by: Xiaoling Huang, et al.
Published: (2023-02-01) -
Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer
by: Hee Eun Kang, et al.
Published: (2021-07-01) -
Niclosamide and Pyrvinium Are Both Potential Therapeutics for Osteosarcoma, Inhibiting Wnt–Axin2–Snail Cascade
by: Young Yi, et al.
Published: (2021-09-01) -
PNU-74654 Induces Cell Cycle Arrest and Inhibits EMT Progression in Pancreatic Cancer
by: Tai-Long Chien, et al.
Published: (2023-08-01)